CEA and CA 19-9 are Still Valuable Markers for the Prognosis of Colorectal and Gastric Cancer Patients |
Sisik, Abdullah
(Bingol State Hospital)
Kaya, Mustafa (Kangal State Hospital) Bas, Gurhan (Umraniye Education and Research Hospital) Basak, Fatih (Umraniye Education and Research Hospital) Alimoglu, Orhan (Umraniye Education and Research Hospital) |
1 | Basbug M, Arikanoglu Z, Bulbuller N, et al (2011). Prognostic value of preoperative CEA and CA 19-9 levels in patients with colorectal cancer. Hepato-Gastroenterology, 58, 400-5. |
2 | Carpelan-Holmstrom M, Louhimo J, Stenman UH, et al (2002). CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res, 22, 2311-5. |
3 | Cooper HS (2004). Intestinal neoplasma. In Mills SE (eds): Sternberg's Diagnostic Surgical Pathology Lipincott Williams and Wilkins, 1543-58. |
4 | Dalton P, Chandrasoma P (1999). Colorectal malignant neoplasm. In Chandrasoma P (eds): Gastrointestinal Pathology 1st Edition. Stamford Connecticut: Appleton and Lange, 339-26. |
5 | Dong H, Tang J, Li LH, et al (2013).Serum carbohydrate antigen 19-9 as an indicator of liver metastasis in colorectal carcinoma cases. Asian Pac J Cancer Prev, 14, 1965-3. DOI ScienceOn |
6 | Duraker N, Celik AN (2001). The prognostic significance of preoperative serum CA 19-9 in patients with respectable gastric carcinoma: comparison with CEA. J Surg Oncol, 76, 266-5. DOI ScienceOn |
7 | Gonzales A, Vizoso F, Allende MT, et al (1996). Preoperative CEA and TAG-72 serum levels as prognostic indicators in resectable gastric carcinoma. Int J Biol Markers, 11, 165-6. |
8 | Hamilton SR, Vogelstein B, Kudo S, et al (2000). Tumors of colon and rectum. In Hamilton SR, Altonen LA (eds): World health organisation classification of tumors. Pathology and genetics of tumors of the digestive system. France: IARC Pres, 103-40. |
9 | Hammond EH (2002). Quality control and standardization for tumor markers. In Diamandis EP, Fritsche HA, Lilja H, Chan DW, Schwartz MK (eds): Tumor markers: Physiology, Pathobiology, Technology and Clinical Applications. AACC Press, 25-7. |
10 |
Harada H, Tsukada Y, Karasawa Y (1994). Evaluation of tumorassociated antigen ( |
11 | Harpaz N, Saxena R. (2003). Gastrointestinal tract. Large Intestine. In Weidner N, Cote RJ, Suster S et al. (eds): Modern Surgial Pathology 2nd Edition. Saunders 749-103. |
12 | Huh JW, Oh BR, Kim BR, Kim JY (2010). Preoperative carcinoembriyonic antigen level as an independent prognostic factor in potentially curative colon cancer. J Surg Oncol, 101, 396-400. |
13 | Jass JR (2000). Tumours of the small and large intestines (Including the Anal region). In Fletcher CDM, Christopher D. (eds): Diagnostic Histopathology of Tumours 2nd Edition. Livingstone, 369-40. |
14 | Mahmoud N, Rombeau J, Ross HM (2010). Colon and rectum. In Towsend CM, evers BM, beaucamps RD, mattox KL (eds): Sabiston Textbook of Surgery: the Biological Basis of Modern Surgical Practice 17th Edition. Saunders, 1401-83. |
15 | Park YA, Lee KY, Kim NK, et al (2006). Prognostic effect of perioperative change of serum carcinoembriyonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Ann Surg Oncol, 13, 645-50. DOI ScienceOn |
16 | McLeod HL, Murray GI (1999). Tumour markers of prognosis in colorectal cancer. Br J Cancer, 79, 191-203. DOI ScienceOn |
17 | Mihmanli M, Dilege E, Demir U, et al (2004). The use of tumor markers as predictors of prognosis in gastric cancer. Hepatogastroenterol, 51, 1544-7. |
18 | Mittal A, Gupta SP, Jha DK, Sathian B, Poudel B (2013). Impact of various tumor markers in prognosis of gastric cancer. a hospital based study from Tertiary Care Hospital of Kathmandu Valley. Asian Pac J Cancer Prev, 14, 1965-3. DOI ScienceOn |
19 | Redston M (2004) Epithelial Neoplasms of the GI Tract (Large Intestine). In Odze RD, Goldblum JR (eds): Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas 1st Edition. Saunders, 441-31. |
20 | Reiter W, Steiber P, Reuter C, et al (2000). Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Res, 20, 5195-8. |
21 | Tocchi A, Costa G, Lepre L, et al (1998). The role of serum and gastric juice levels of carcinoembryonic antigen, CA 19.9 and CA 72.4 in patients with gastric cancer. J Cancer Res Clin Oncol, 124, 450-5. DOI |
22 | Ucar E, Semerci E, Ustun H, et al (2008). Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Adv Ther, 25, 1075-9. DOI ScienceOn |
23 | Uehara K, Miyamoto Y, Izuo M, et al (1985). Significance of CEA in gastric and colorectal cancer. Nippon Geka Gakkai Zasshi, 86, 435-7. |
24 | Wanebo HJ, Rao B, Pinsky CM, et al (1978). Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl Med, 299, 448-3. DOI ScienceOn |
25 | Ychou M, Duffour J, Kramar A, et al (2000). Clinical significance and prognostic value of CA 72-4 compared with CEA and CA 19-9 in patients with gastric cancer. Dis Markers, 16, 105-5. DOI |
26 | Yakabe T, Nakafusa Y, Sumi K, et al (2010). Clinical significance of CEA and CA 19-9 in postoperative follow-up of colorectal cancer. Ann Surg Oncol, 17, 2349-56. DOI |
27 | Yamashita K, Sakuramoto S, Kikuchi S, et al (2007). Surgical resection of stage IV gastric cancer and prognosis. Anticancer Res, 27, 4381-5. |
28 | Yang XQ, Li Y, Chen C, et al (2001). Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer. Med Oncol, 28, 789-6. |
29 | Zheng CX, Zhan WH, Zhao JZ, et al (2001). The prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in patients with colorectal cancer. World J Gastroentero, 7, 431-3. |
![]() |